Clinical Trial Update: Reducing Hemarthrosis in ACL Reconstruction With BTB Autograft by the Administration of Intravenous TXA [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravenous tranexamic acid to reduce hemarthrosis after ACL reconstruction with BTB autograft has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Reconstruction

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: NYU Langone Health | Conditions: Anterior Cruciate Ligament Reconstruction | Phase 4 | Status: COMPLETED | Results posted: 2021-02-24